Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000122327 | SCV000310537 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000314393 | SCV000441369 | benign | Xeroderma pigmentosum, group C | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Labcorp Genetics |
RCV001513522 | SCV001721150 | benign | not provided | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000122327 | SCV001737748 | benign | not specified | 2021-06-16 | criteria provided, single submitter | clinical testing | Variant summary: XPC c.2061G>A results in a synonymous change. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.25 in 245744 control chromosomes in the gnomAD database, including 8333 homozygotes. The observed variant frequency is approximately 357 fold of the estimated maximal expected allele frequency for a pathogenic variant in XPC causing Xeroderma Pigmentosum phenotype (0.00071), strongly suggesting that the variant is benign. The variant c.2061G>A, has been reported in the literature (example: PMID: 27285993, 10766188). One ClinVar submitter (evaluation after 2014) cites the variant as benign. Based on the evidence outlined above, the variant was classified as benign. |
Gene |
RCV001513522 | SCV001882116 | benign | not provided | 2019-01-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000314393 | SCV002514000 | benign | Xeroderma pigmentosum, group C | 2021-12-05 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003315790 | SCV004016280 | benign | Xeroderma pigmentosum group A | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001513522 | SCV005241619 | benign | not provided | criteria provided, single submitter | not provided | ||
KCCC/NGS Laboratory, |
RCV000314393 | SCV005880484 | benign | Xeroderma pigmentosum, group C | 2025-02-01 | criteria provided, single submitter | clinical testing | |
ITMI | RCV000122327 | SCV000086557 | not provided | not specified | 2013-09-19 | no assertion provided | reference population |